{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:39:39Z","timestamp":1761100779900},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T00:00:00Z","timestamp":1113436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T00:00:00Z","timestamp":1113436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1038\/sj.leu.2403745","type":"journal-article","created":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T11:59:32Z","timestamp":1113479972000},"page":"1029-1033","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis"],"prefix":"10.1038","volume":"19","author":[{"given":"P","family":"Dreger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Milligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Finke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Lambertenghi Deliliers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"van Biezen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Michallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Niederwieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Chronic Leukemia Working Party of the EBMT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,4,14]]},"reference":[{"key":"BF2403745_CR1","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H D\u00f6hner","year":"2000","unstructured":"D\u00f6hner H, Stilgenbauer S, Benner A, Leupolt E, Kr\u00f6ber A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910\u20131916.","journal-title":"N Engl J Med"},{"key":"BF2403745_CR2","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840\u20131847.","journal-title":"Blood"},{"key":"BF2403745_CR3","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK . Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848\u20131854.","journal-title":"Blood"},{"key":"BF2403745_CR4","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1056\/NEJMoa023143","volume":"348","author":"M Crespo","year":"2003","unstructured":"Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003; 348: 1764\u20131775.","journal-title":"N Engl J Med"},{"key":"BF2403745_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1046\/j.1365-2141.1997.272673.x","volume":"97","author":"IF Khouri","year":"1997","unstructured":"Khouri IF, Przepiorka D, van BK, O'Brien S, Palmer JL, Lerner S et al. Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease. Br J Haematol 1997; 97: 466\u2013473.","journal-title":"Br J Haematol"},{"key":"BF2403745_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/sj.bmt.1702237","volume":"25","author":"ZS Pavletic","year":"2000","unstructured":"Pavletic ZS, Arrowsmith ER, Bierman PJ, Goodman SA, Vose JM, Tarantolo SR et al. Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia. Bone Marrow Transplant 2000; 25: 717\u2013722.","journal-title":"Bone Marrow Transplant"},{"key":"BF2403745_CR7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/sj.leu.2402036","volume":"15","author":"J Esteve","year":"2001","unstructured":"Esteve J, Villamor N, Colomer D, Cervantes F, Campo E, Carreras E et al. Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status. Leukemia 2001; 15: 445\u2013451.","journal-title":"Leukemia"},{"key":"BF2403745_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/sj.bmt.1703548","volume":"29","author":"KC Doney","year":"2002","unstructured":"Doney KC, Chauncey T, Appelbaum FR . Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia. Bone Marrow Transplant 2002; 29: 817\u2013823.","journal-title":"Bone Marrow Transplant"},{"key":"BF2403745_CR9","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/sj.leu.2402530","volume":"16","author":"P Dreger","year":"2002","unstructured":"Dreger P, Montserrat E . Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia. Leukemia 2002; 16: 985\u2013992.","journal-title":"Leukemia"},{"key":"BF2403745_CR10","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1200\/JCO.2003.12.011","volume":"21","author":"J Schetelig","year":"2003","unstructured":"Schetelig J, Thiede C, Bornhauser M, Schwerdtfeger R, Kiehl M, Beyer J et al. Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group. J Clin Oncol 2003; 21: 2747\u20132753.","journal-title":"J Clin Oncol"},{"key":"BF2403745_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.exphem.2003.09.021","volume":"32","author":"IF Khouri","year":"2004","unstructured":"Khouri IF, Lee MS, Saliba RM, Andersson B, Anderlini P, Couriel D et al. Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival. Exp Hematol 2004; 32: 28\u201335.","journal-title":"Exp Hematol"},{"key":"BF2403745_CR12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/sj.leu.2402905","volume":"17","author":"P Dreger","year":"2003","unstructured":"Dreger P, Brand R, Hansz J, Milligan D, Corradini P, Finke J et al. Low treatment-related mortality but retained graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using reduced-intensity conditioning. Leukemia 2003; 17: 841\u2013848.","journal-title":"Leukemia"},{"key":"BF2403745_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1182\/blood-2003-05-1406","volume":"103","author":"RD Faulkner","year":"2004","unstructured":"Faulkner RD, Craddock C, Byrne JL, Mahendra P, Haynes AP, Prentice HG et al. BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients. Blood 2004; 103: 428\u2013434.","journal-title":"Blood"},{"key":"BF2403745_CR14","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1182\/blood-2002-03-0701","volume":"100","author":"JA Perez-Simon","year":"2002","unstructured":"Perez-Simon JA, Kottaridis PD, Martino R, Craddock C, Caballero D, Chopra R et al. Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders. Blood 2002; 100: 3121\u20133127.","journal-title":"Blood"},{"key":"BF2403745_CR15","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.1182\/blood-2001-11-0107","volume":"100","author":"SP Robinson","year":"2002","unstructured":"Robinson SP, Goldstone AH, Mackinnon S, Carella A, Russell N, De Elvira CR et al. Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation. Blood 2002; 100: 4310\u20134316.","journal-title":"Blood"},{"key":"BF2403745_CR16","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1182\/blood-2003-12-4321","volume":"104","author":"M Ritgen","year":"2004","unstructured":"Ritgen M, Stilgenbauer S, von Neuhoff N, Humpe A, Br\u00fcggemann M, Pott C et al. Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy chain gene status: implications of minimal residual disease measurement with quantitative PCR. Blood 2004; 104: 2600\u20132602.","journal-title":"Blood"},{"key":"BF2403745_CR17","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/sj.leu.2403478","volume":"18","author":"S B\u00f6ttcher","year":"2004","unstructured":"B\u00f6ttcher S, Ritgen M, Pott C, Br\u00fcggemann M, Raff T, Stilgenbauer S et al. Comparative analysis of minimal residual disease detection using four color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation. Leukemia 2004; 18: 1637\u20131645.","journal-title":"Leukemia"},{"key":"BF2403745_CR18","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1182\/blood-2004-03-0804","volume":"104","author":"R Diaconescu","year":"2004","unstructured":"Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, Maloney DG et al. Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood 2004; 104: 1550\u20131558.","journal-title":"Blood"},{"key":"BF2403745_CR19","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1182\/blood-2002-05-1340","volume":"101","author":"D Niederwieser","year":"2003","unstructured":"Niederwieser D, Maris M, Shizuru JA, Petersdorf E, Hegenbart U, Sandmaier BM et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 2003; 101: 1620\u20131629.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403745.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403745","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403745.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:31:10Z","timestamp":1648776670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,14]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6,1]]}},"alternative-id":["BF2403745"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403745","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"type":"print","value":"0887-6924"},{"type":"electronic","value":"1476-5551"}],"subject":[],"published":{"date-parts":[[2005,4,14]]},"assertion":[{"value":"30 August 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}